IPO registrations (S-1, F-1) · Registrants
Vanda Pharmaceuticals Inc.
- SEC CIK
- 1347178 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2005-12-29, last 2007-01-17; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2006-04-13; declared effective 2007-01-18
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, Washington, DC 20037
- EIN
- 03-0491827
- Ticker
- VNDA (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Vanda Pharmaceuticals Inc. on the corporate pages
On this site
- Business registration: VANDA PHARMACEUTICALS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Vanda Pharmaceuticals Inc Fuzzy (name and state)
- Business registration: Vanda Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: VANDA PHARMACEUTICALS INC. Fuzzy (name and state)
- Business registration: VANDA PHARMACEUTICALS INC. Fuzzy (name and state)
- Business registration: VANDA PHARMACEUTICALS, INC Fuzzy (name and state)
- Business registration: VANDA PHARMACEUTICALS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: VANDA PHARMACEUTICALS INC. EXACT (EIN (EXACT))
- Federal award recipient: VANDA PHARMACEUTICALS INC. Fuzzy (name and state)
- Lobbying client: VANDA PHARMACEUTICALS INC Fuzzy (name and state)
- Lobbying client: VANDA PHARMACEUTICALS INC. Fuzzy (name and state)
- SEC filer: Vanda Pharmaceuticals Inc. EXACT (CIK (EXACT))
- Person page: Anne Sempowski Ward Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: Richard L Gulino Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-12-29 | S-1 | S-1 (registration) | Vanda Pharmaceuticals Inc. | 0000950123-05-015355 ↗ |
| 2006-02-16 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950135-06-000892 ↗ |
| 2006-03-17 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950133-06-001354 ↗ |
| 2006-03-28 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950123-06-003802 ↗ |
| 2006-04-07 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950123-06-004400 ↗ |
| 2006-04-11 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950123-06-004498 ↗ |
| 2006-04-12 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950135-06-002303 ↗ |
| 2006-04-13 | 424B4 | 424B4 (final prospectus) | Vanda Pharmaceuticals Inc. | 0000950135-06-002339 ↗ |
| 2006-12-19 | S-1 | S-1 (registration) | Vanda Pharmaceuticals Inc. | 0000950123-06-015373 ↗ |
| 2007-01-09 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950133-07-000074 ↗ |
| 2007-01-17 | S-1/A | S-1/A (amendment) | Vanda Pharmaceuticals Inc. | 0000950133-07-000143 ↗ |
| 2007-01-18 | S-1MEF | S-1MEF (added securities) | Vanda Pharmaceuticals Inc. | 0000950135-07-000234 ↗ |
| 2007-01-18 | EFFECT | EFFECT (declared effective) | Vanda Pharmaceuticals Inc. | 9999999995-07-000218 ↗ |
| 2007-01-19 | 424B4 | 424B4 (final prospectus) | Vanda Pharmaceuticals Inc. | 0000950135-07-000237 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARKAS ALEXANDER E | TenPercentOwner | 3 | 2006 | ||
| Biomedical Sciences Investment Fund Pte Ltd. | TenPercentOwner | 5 | 2006 | ||
| Bio One Capital Pte Ltd. | TenPercentOwner | 5 | 2006 | ||
| BLAIR JAMES C | TenPercentOwner | 4 | 2006 | ||
| CARE CAPITAL II LLC | TenPercentOwner | 9 | 2006 | ||
| CARE CAPITAL INVESTMENTS II LP | TenPercentOwner | 9 | 2006 | ||
| Care Capital Offshore Investments II LP | TenPercentOwner | 9 | 2006 | ||
| Clark William D | Officer | Sr VP, Chief Business Officer; Sr. VP, Chief Business Officer | 21 | 2006–2010 | |
| Copmann Thomas Lyle | Officer | VP of Regulatory Affairs | 1 | 2006 | |
| Domain Partners VI, L.P. | TenPercentOwner | 4 | 2006 | ||
| DOVEY BRIAN H | TenPercentOwner | 4 | 2006 | ||
| DP VI Associates, L.P. | TenPercentOwner | 3 | 2006 | ||
| DUGAN RICHARD W | Director | 27 | 2006–2026 | ||
| EDB Investments Pte Ltd. | TenPercentOwner | 5 | 2006 | ||
| Halak Brian K | Director | 5 | 2006–2010 | ||
| HIRSCH RUSSELL C | TenPercentOwner | 3 | 2006 | ||
| HOCKMEYER WAYNE T | Director | 2 | 2006 | ||
| KAIROUZ HABIB | TenPercentOwner | 4 | 2006 | ||
| KARABELAS ARGERIS N | Director; Director,Officer | Chairman of the Board | 22 | 2006–2011 | |
| LESCHLY JAN | TenPercentOwner | 9 | 2006 | ||
| LESCHLY MARK | TenPercentOwner | 4 | 2006 | ||
| MEDIMMUNE INC /DE | TenPercentOwner | 2 | 2006 | ||
| MORE ROBERT J | TenPercentOwner | 4 | 2006 | ||
| Phadke Deepak Shripad | Officer | Vice President Manufacturing; VP of Manufacturing | 2 | 2006 | |
| Polymeropoulos Mihael Hristos | Director,Officer; Director,Officer,Other; Director,OfficerOther; Officer | Chief Executive Officer; President and CEO | 83 | 2006–2026 | |
| PROSPECT ASSOCIATES II L P | TenPercentOwner | 3 | 2006 | ||
| PROSPECT MANAGEMENT CO II LLC | TenPercentOwner | 3 | 2006 | ||
| PROSPECT VENTURE PARTNERS II LP | TenPercentOwner | 3 | 2006 | ||
| Ramsay David Russ | Director; Other | 20 | 2006–2010 | ||
| RHO CAPITAL PARTNERS INC | TenPercentOwner | 4 | 2006 | ||
| RHO CAPITAL PARTNERS VERWALTUNGS GMBH | TenPercentOwner | 4 | 2006 | ||
| RHO MANAGEMENT TRUST I | TenPercentOwner | 4 | 2006 | ||
| RHO MANAGEMENT VENTURES IV LLC | TenPercentOwner | 4 | 2006 | ||
| RHO VENTURES IV GMBH & CO BETEILIGUNGS KG | TenPercentOwner | 4 | 2006 | ||
| RHO VENTURES IV LP | TenPercentOwner | 4 | 2006 | ||
| RHO VENTURES IV QP LP | TenPercentOwner | 4 | 2006 | ||
| RUCH JOSHUA | TenPercentOwner | 4 | 2006 | ||
| SCHNELL DAVID | TenPercentOwner | 3 | 2006 | ||
| SCHOEMAKER KATHLEEN K | TenPercentOwner | 4 | 2006 | ||
| SHALLCROSS STEVEN A | Officer | Sr. VP, CFO, Treasurer | 15 | 2006–2008 | |
| TANANBAUM JAMES B | Director | 5 | 2006–2007 | ||
| TREU JESSE I | TenPercentOwner | 4 | 2006 | ||
| VITULLO NICOLE | TenPercentOwner | 4 | 2006 | ||
| Baroldi Paolo | Officer | Chief Medical Officer; SVP & Chief Medical Officer | 14 | 2006–2017 | |
| Watkins Thomas | Director | 22 | 2006–2022 | ||
| PIEN HOWARD H | Director | 10 | 2007–2015 | ||
| Gianchetti Albert W. | Officer | Sr.VP,Chief Commercial Officer | 3 | 2007–2008 | |
| TANG CAPITAL MANAGEMENT LLC | TenPercentOwner | 16 | 2008–2010 | ||
| TANG CAPITAL PARTNERS LP | TenPercentOwner | 16 | 2008–2010 | ||
| TANG KEVIN C | TenPercentOwner | 16 | 2008–2010 | ||
| Feeney John Joseph | Officer | Acting Chief Medical Officer; Chief Medical Officer; SVP & Chief Medical Officer | 16 | 2009–2012 | |
| Irish Stephanie Rast | Officer | Acting CFO/Treasurer; Sr. VP, Acting CFO/Treasurer; Sr. VP, CFO, Treasurer | 8 | 2009–2010 | |
| MILANO VINCENT | Director | 11 | 2010–2018 | ||
| Galson Steven K | Director | 7 | 2010–2014 | ||
| Kelly James Patrick | Officer | EVP & Chief Financial Officer; SVP, CFO, Sec & Treasurer; SVP, CFO & Treasurer; SVP, CFO, Treasurer & Secretar | 25 | 2010–2020 | |
| Repella Robert | Officer | SVP & Cheif Commercial Officer; SVP & Chief Commercial Officer | 6 | 2011–2013 | |
| COLA MICHAEL F | Director | 9 | 2012–2019 | ||
| Deerfield International Master Fund, L.P. | TenPercentOwnerOther | 8 | 2014–2016 | ||
| DEERFIELD MANAGEMENT CO | TenPercentOwnerOther | 8 | 2014–2016 | ||
| Deerfield Mgmt L.P. | TenPercentOwnerOther | 8 | 2014–2016 | ||
| DEERFIELD PARTNERS, L.P. | TenPercentOwnerOther | 8 | 2014–2016 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 7 | 2014–2016 | ||
| Deerfield Special Situations International Master Fund, L.P. | TenPercentOwnerOther | 1 | 2014 | ||
| Flynn James E | TenPercentOwnerOther | 8 | 2014–2016 | person page Fuzzy | |
| Gibbs Thomas Edward | Officer | SVP, Chief Commercial Officer | 2 | 2015 | |
| Reverberi Gian Piero | Officer | SVP, Acting CCO & GM Europe; SVP & Chief Commercial Officer; SVP, General Manager Europe | 12 | 2015–2020 | |
| Gulino Richard L. | Officer | SVP & General Counsel; SVP, General Counsel & Sec. | 7 | 2015–2018 | person page Fuzzy |
| BATE KENNETH | Director | 4 | 2015–2017 | ||
| Birznieks Gunther | Officer | SVP, Business Development | 21 | 2017–2026 | |
| Williams Timothy | Officer | SVP & General Counsel | 23 | 2018–2026 | |
| Chrousos Phaedra | Director | 11 | 2019–2026 | ||
| Jones Aranthan II | Officer | Chief Corp. Affairs Officer | 9 | 2019–2021 | |
| Wijkstrom Joakim | Officer | SVP, Chief Marketing Officer | 18 | 2019–2026 | |
| Ward Anne Sempowski | Director | 9 | 2019–2026 | person page Fuzzy | |
| Mitchell Stephen Ray | Director | 16 | 2020–2026 | ||
| Moran Kevin Patrick | Officer | SVP, CFO & Treasurer; VP, Acting CFO & Treasurer | 20 | 2020–2026 | |
| Honore Tage | Director | 7 | 2023–2026 | ||
| Howell Scott Laverne | Officer | VP and Chief People Officer | 1 | 2026 | |
| Polymeropoulos Christos Vasilios Mihael | Officer | Senior VP, Medical Director | 1 | 2026 | |
| Duncan Charles Cliff | Director | 3 | 2026 | ||
| McGuire Daniel Patrick | Officer | SVP, GC and Secretary | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.